A Study of Guselkumab for the Treatment of Participants With Crohn's Disease After Surgical Resection
Clinical trial NCT05784129 · TERMINATED
Trial details
- NCT number
- NCT05784129
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-21
- Primary completion
- 2023-09-29
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.